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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative virus
for the current global pandemic known as coronavirus disease 2019 (COVID-19).
SARS-CoV-2 belongs to the family of single-stranded RNA viruses known as
coronaviruses, including the MERS-CoV and SARS-CoV that cause Middle East
respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS),
respectively. These coronaviruses are associated in the way that they cause mild
to severe upper respiratory tract illness. This study has used an unbiased analysis
of publicly available gene expression datasets from Gene Expression Omnibus to
understand the shared and unique transcriptional signatures of human lung epithelial
cells infected with SARS-CoV-2 relative to MERS-CoV or SARS-CoV. A major goal was
to discover unique cellular responses to SARS-CoV-2 among these three coronaviruses.
Analyzing differentially expressed genes (DEGs) shared by the three datasets led
to a set of 17 genes, suggesting the lower expression of genes related to acute
inflammatory response (TNF, IL32, IL1A, CXCL1, and CXCL3) in SARS-CoV-2. This
subdued transcriptional response to SARS-CoV-2 may cause prolonged viral replication,
leading to severe lung damage. Downstream analysis of unique DEGs of SARS-CoV-2
infection revealed changes in genes related to apoptosis (NRP1, FOXO1, TP53INP1,
CSF2, and NLRP1), coagulation (F3, PROS1, ITGB3, and TFPI2), and vascular function
(VAV3, TYMP, TCF4, and NR2F2), which may contribute to more systemic cardiovascular
complications of COVID-19 than MERS and SARS. The study has uncovered a novel
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set of transcriptomic signatures unique to SARS-CoV-2 infection and shared by three
coronaviruses, which may guide the initial efforts in the development of prognostic or
therapeutic tools for COVID-19.
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INTRODUCTION
The novel severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) belongs to the Coronaviridae family of
viruses (coronaviruses) and is responsible for the coronavirus
disease 2019 (COVID-19) pandemic (1). Along with its other
accomplices, Middle East respiratory syndrome coronavirus
(MERS-CoV) and severe acute respiratory syndrome coronavirus
(SARS-CoV), SARS-CoV-2 can jump species barrier followed
by human-to-human transmission via droplet infection. In late
December 2019, initial reports suggested the origin of SARS-
CoV-2 in a seafood and wild animal trading market in Wuhan,
China (2). To date, the pandemic has caused more than 83
million infections and more than 1.8 million deaths worldwide
(https://www.worldometers.info/coronavirus/). SARS-CoV-2
leads to more cardiovascular complications than do MERS-CoV
and SARS-CoV; however, what causes these major differences
remains obscure (3, 4).
The initial genome identification of SARS-CoV-2 suggested
that it has a ∼80% similarity with SARS-CoV and 96% identical
to a bat coronavirus; however, there are differences in its
pathogenicity and host response (2). The virus nucleic acid
shedding patterns in both symptomatic and asymptomatic
patients of SARS-CoV-2 are similar, which explains the
transmission potential of otherwise asymptomatic carriers (5). In
contrast, the viral burden in the upper respiratory tract in SARS-
CoV infection peaks at around 10 days after the initial exposure
(6). On the contrary to SARS-CoV-2, viral load in MERS-CoV–
infected individuals peak at week 2 of the onset of infection (7).
This suggests the difference in the virulence and host response of
these three strains.
Upon entry, next steps are viral replication, amplification,
and spread in the host, which largely depend on similarities
and/or uniquenesses in transcriptional signature of these
viruses. Patients with SARS-CoV-2 manifest a few different
but aggravated symptoms, particularly major cardiovascular
complications, from SARS-CoV and MERS-CoV, which may be
attributable to the difference in their transcriptional signatures.
Reports of aggravated blood coagulation in COVID-19 patients
suggested the mechanism of prominent elevation of D-dimer and
fibrin/fibrinogen degradation products (8). Higher mortality rate
is reported in COVID-19 patients with thromboembolic events
(9), and treatment with anticoagulant-heparin has improved
prognosis (10).
The present comparative analysis has determined key
differences in transcriptional changes in lung epithelial cells
induced by these virus strains. To further examine transcriptional
responses of SARS-CoV-2 and other two coronaviruses, we
analyzed a comprehensive map of lung epithelial cells infected
with these three coronaviruses and explored pathological host
responses unique to SARS-CoV-2. Our findings may help
to understand potential mechanisms by which SARS-CoV-
2 causes more cardiovascular complications than do two
other coronaviruses and to establish molecular bases for the
development of therapies against COVID-19.
METHODS
RNA Sequencing and Microarray Analysis
of Gene Expression Omnibus Datasets
Figure 1A depicts the workflow of gene expression analysis. For
differential gene expression analysis of SARS-CoV-2 infection,
raw expression counts were downloaded from Gene Expression
Omnibus (GEO) accession number GSE147507 (11). RNA
sequencing (RNAseq) dataset was generated on Illumina Nextseq
500 platform. The raw read counts were normalized by
log2 transformation, before and after normalization box plot;
principal component analysis (PCA) and density plot are shown
in Supplementary Figure 1. Using INMEX tool that employs
DESeq (12, 13), differential expression analysis was performed
and differentially expressed genes (DEGs) were characterized
for each sample with adjusted p < 0.05 [false discovery rate
(FDR) corrected by Benjamini–Hochberg method]. GSE81909,
the dataset we used for analysis of MERS-CoV, was generated
on Agilent-Whole Human Genome Microarray 4x44K G4112.
After downloading the raw read counts from GEO, we
normalized the dataset using variance-stabilizing normalization
followed by quantile normalization (14). Before and after
normalization box plot, PCA and density plot are shown in
Supplementary Figure 2. Similarly, we downloaded raw read
counts of GSE17400 (15) for analysis of SARS-CoV infection.
This dataset was generated on Affymetrix Human Genome U133
plus 2.0 Array. After normalization of dataset using variance-
stabilizing normalization followed by quantile normalization
(Supplementary Figure 3), both microarray datasets, GSE81909
and GSE17400, were subjected to DEGs analysis using LIMMA
algorithm (16). DEGs were characterized for each sample with
adjusted p < 0.05 (FDR corrected by Benjamini–Hochberg
method). Heatmap visualization of a subset of 25 overexpressed
and underexpressed genes was constructed using heatmap.2 from
the gplot package in R. Volcano plots were constructed using
custom scripts in R, and PCAwas performed on log2 fold-change
values using PMA package in R (17) (Supplementary Figure 4).
It is worthwhile mentioning that all three datasets used in this
study are collected from different laboratories and using different
cell lines, as well as experimental techniques (e.g., microarrays,
RNAseq). We selected RNAseq dataset for SARS-CoV-2 as
there were especially no microarray datasets on SARS-CoV-2
in humans. Therefore, we did take the present analysis strategy
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of comparing each dataset with its internal control to call the
DEGs for each coronavirus infection. Further, we compared the
three sets of DEGs to find the shared and unique genes between
coronavirus infections; we applied this strategy to minimize
data variabilities (e.g., operator and platform biases). GSE147507
was generated in primary human lung epithelium (NHBE);
GSE81909 was generated in human airway epithelial cells,
whereas GSE17400 was generated in human bronchial epithelial
cells. Supplementary Table 1 provides detailed information of
each dataset and sequencing/microarray platform used.
Functional Gene Set Enrichment Analysis
of DEGs
To discern the implication of DEGs called from transcriptome
analysis of coronavirus infection in lung epithelial cells, we
performed a functional analysis using the EnrichR platform
(18). This web-based software product evaluates significantly
enriched pathways/terms in an input gene list with the help of
its extensive gene set libraries, which includes Gene Ontology
(GO) (19) and various pathway analysis libraries such as
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway,
Reactome pathway, wikipathway, Panther, and Biocarta. We
retrieved tables of enriched pathways from each database and
prepared a comprehensive table of most significant pathways for
each coronavirus infection based on the adjusted p value (ranking
derived from Fisher exact test for gene sets) significance.
Common DEGs Analysis Between
Coronaviruses
We created a coronavirus–gene network for better visualization
of the shared genes between the coronaviruses using Cytoscape
software (20). The network was generated by utilizing the list of
DEGs from three coronaviruses studies in which coronaviruses
are the source nodes; genes are the target nodes, and the
connections between them are the edges in the network. The
network core represents the coronaviruses, whereas the inner-
circle genes in the network are the shared ones, and outer-
circle genes are unique to each coronavirus (Figure 2C). A
Venn diagram representing the shared and unique DEG portion
between three coronaviruses was generated using VENNY
2.1 tool (https://bioinfogp.cnb.csic.es/tools/venny/index.html). A
heatmap represents the expression profiles for common DEGs
between coronaviruses. Clustering of selected genes on the
heatmap was performed by hierarchical clustering algorithm
utilizing Euclidean distance measure.
Pathway Clustering and Network-Based
Hub Gene Analysis
For visualization and interpretation of the biological relevance
of unique DEGs to SARS-CoV-2 DEGs, Cytoscape v3.1 plug-
in was used for analysis. Biological pathway clustering analysis
was done using BinGO (21). BinGO analyzes GO terms and
functional groups association within the biological networks. We
performed biological pathway clustering analysis to see collective
function of these genes. The size of a node is proportional to
the number of targets in the biological process category. The
color represents enrichment significance—the deeper the color
on a color scale, the higher the enrichment significance. Hub
gene network analysis was performed using NetworkAnalyst
(13), which created a protein–protein interaction (PPI) network
by integrating the InnateDB interactome with the original
seed of 221 DEGs. This tool supports integrative analysis of
gene expression data through statistical, visual, and network-
based analysis approaches by taking the advantage of common
functions for network topology and module analysis approaches.
Briefly, the complete list of unique DEGs from SARS-CoV-2
was uploaded into the web-based server of NetworkAnalyst.
Network construction was restricted to contain all the original
seed proteins in order to visualize the connections. To help
identify highly interconnected hub nodes, topological measures
(e.g., degree and betweenness centrality) were used. Expression
of the genes was considered as the network feature, where red-
colored nodes are genes with increased expression, green nodes
are genes with decreased expression, and gray nodes are genes
not expressed in our data.
Expression2Kinases Analysis of
Regulatory Gene Networks
ChEA is a comprehensive databases of kinases and transcription
factors (22), and it is used in background of Expression2Kinases
(X2K) (23), the tool we used to understand the upstream
regulatory molecules of DEGs in SARS-CoV-2 infection. The
10 most significant transcription factors and kinases were
extracted based on Fisher exact test p value enrichment
scoring. We downloaded the “.graphml” file generated from
the analysis to create and visualize regulatory network on
Cytoscape environment. This ensures that the protein network
obtained during network expansion is properly connected by
automatically increasing the path length, so that there are more
intermediate proteins used to connect the transcription factors.
In the network, a yellow node represents intermediate proteins in
the PPI regulatory network. Node size represents the significance
of protein based on adjusted p value; the bigger the nodes size,
the higher the significance value.
Statistical Analyses
For differential expression analysis of SARS-CoV-2 dataset
GSE147507, read counts were subjected to differential expression
analysis using INMEX, which utilizes the Rpackage DESeq
(13). Genes with adjusted p < 0.05 were considered significant.
The p value adjustment for multiple comparisons was done by
the Benjamini–Hochberg method. For MERS-CoV-GSE81909
and SARS-CoV-GSE17400, differential expression analysis
was performed with LIMMA algorithm for each dataset,
independently using adjusted p < 0.05, based on the FDR
using the Benjamini–Hochberg method and moderated t
test. Significantly enriched GO terms were identified using
hypergeometric tests, and p ≤ 0.05 was applied as a cutoff for
statistical significance.
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FIGURE 1 | Gene expression profiles of the differentially expressed genes (DEGs) in human lung epithelial cells infected with coronaviruses. (A) Workflow of gene
expression analysis. Selection process of eligible datasets for transcriptome analysis was based on datasets generated from infection of human lung epithelial cell in
culture with SARS-CoV-2, MERS-CoV, or SARS-CoV. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; CoV, coronavirus; MERS-CoV, Middle East
respiratory syndrome coronavirus; SARS-CoV, severe acute respiratory syndrome coronavirus and GEO, Gene Expression Omnibus. (B–D) Heatmaps of expression
profiles for the top 25 increased and 25 decreased DEGs obtained from RNA-seq data analysis. Clustering of selected genes on the heatmap was performed by
hierarchical clustering algorithm using Euclidean distance measure. (B) SARS-CoV-2, (C) MERS-CoV, and (D) SARS-CoV.
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FIGURE 2 | Shared transcriptional signatures between the three coronaviruses. (A) Venn diagram representing the shared and unique DEGs portion between three
coronaviruses. (B) Heatmap representation of expression profiles for the common DEGs between coronaviruses. Clustering of selected genes on the heatmap was
performed by hierarchical clustering algorithm using Euclidean distance measure. Expression scale: blue (low expression) to yellow (high expression). (C)
coronavirus–gene network representing the shared and unique DEGs. Network was created between coronaviruses and their top 100 DEGs on cytoscape platform.
Network core represents the coronaviruses (source nodes) and gene (target nodes). Inner circles of genes in the network are the shared ones, while outer circle genes
are unique to each coronavirus.
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RESULTS
Selection of Eligible Gene Expression
Datasets for Coronavirus Infection in
Human Lung Epithelial Cells
We selected three studies from the GEO accession numbers:
GSE147507 for SARS-CoV-2, GSE81909 for MERS-CoV,
and GSE17400 for SARS-CoV. The search was limited to
transcriptome data generated in human lung epithelial cells.
Figure 1A depicts the overall workflow of the analysis in
this study. A total of 3/3, 20/20, and 9/9 control/infected cell
culture replicates SARS-CoV-2, MERS-CoV, and SARS-CoV,
respectively, were used in this analysis. GSE147507 dataset
was RNAseq data and generated on Illumina Nextseq 500,
and we utilized only six samples (GSM4432378, GSM4432379,
GSM4432380, GSM4432381, GSM4432382, and GSM4432383);
these were independent biological triplicates of primary human
lung epithelium (NHBE), which were mock treated or infected
with SARS-CoV-2 (USA-WA1/2020). Of note, the other two
datasets were generated by microarray using Affymetrix Human
Genome U133A series (GSE17400-SARS-CoV) and Agilent-
014850 Whole Human Genome Microarray 4x44K G4112F
(GSE81909-MERS-CoV). Sample sources of all three datasets
were of human lung epithelial cells and primary lung cells
infected with coronaviruses. Supplementary Table 1 provides
detailed information of each dataset and sequencing/microarray
platform used.
Analysis of Differentially Expressed Genes
(DEGs) in the SARS-CoV-2 Dataset Led to
Perturbation of Inflammatory, Coagulation,
and Apoptotic Pathways
In SARS-CoV-2–infected dataset (GSE147507), we
identified a total of 338 DEGs with adjusted p < 0.05
(Supplementary Dataset 1). Among these 338 DEGs, 92
genes increased, and 246 decreased. Figure 1B depicts the
heatmap of expression of top significant DEGs among the
samples. Table 1 lists the top 20 increased and decreased DEGs
from our analysis of SARS-CoV-2 infection. Interferon (IFN)–
induced transmembrane protein 10 (IFITM10), C-X-C motif
chemokine ligand 14 (CXCL14), and myosin light chain kinase
(MYLK) were among the most significantly increased genes,
while small proline-rich protein 2D (SPRR2D), interleukin 36
gamma (IL36G), and serum amyloid A2 (SAA2) were the most
decreased genes in our analysis of SARS-CoV-2–infected lung
epithelial cells compared to mock controls. When these DEGs
were subjected to the analysis of overrepresented biological
pathways and enriched terms, several pathways related to
inflammation, apoptosis, blood coagulation, and lung fibrosis
were enriched (Table 2). Enriched terms and biological pathways
were significantly overrepresented in the gene list if they showed
an adjusted p < 0.05. DEGs from SARS-CoV-2 infection were
associated with the KEGG pathways such as IL-17 signaling
pathway (hsa04657) with database overlap of 21/93 (which
means of 93 genes associated with this pathway reported in
KEGG, 21 are present among our DEGs) and adjusted p =
1.24E-15 and TNF signaling pathway (hsa04668) with database
overlap of 19/110 and adjusted p = 4.76E-12. Besides, other
databases resulted in enrichment of pathways including blood
coagulation (P00011) with overlap of 7/38 and adjusted p =
1.67E-04, apoptosis signaling pathway (P00006) with overlap of
7/102 and adjusted p = 0.038822, and lung fibrosis (WP3624)
with overlap of 11/63 and adjusted p= 4.53E-07, among others.
Identification of DEG Signature in
MERS-CoV– or SARS-CoV–Infected Human
Lung Epithelial Cells
In the case of MERS-CoV dataset, GSE81909, there are a total of
1,951 DEGs with adjusted p < 0.05 (Supplementary Dataset 2).
Among these 1,951 DEGs, 1,120 genes increased, and 831
decreased. The microarray analysis of GSE17400 for SARS-CoV
infection resulted in a total of 1,521 DEGs with adjusted p <
0.05 (Supplementary Dataset 3). Among these 1,521 DEGs, 475
increased, and 1,046 decreased. Figures 1C,D depict the heatmap
of expression of top significant DEGs among the samples
for MERS-CoV and SARS-CoV, respectively. As shown in
Supplementary Table 2, SSX family member 2 (SSX2), fos proto-
oncogene, AP-1 transcription factor subunit (FOS), and early
growth response 1 (EGR1) were among the most significantly
increased genes, whereas transcription elongation regulator
1 (TCERG1), G protein–coupled receptor 55 (GPR55), and
casein kappa (CSN3) were the most decreased genes in our
analysis of MERS-CoV–infected lung epithelial cells compared to
controls. Similarly, Supplementary Table 3 shows that pentraxin
3 (PTX3), early growth response 1 (EGR1), and EGR2 were
among the most significantly increased genes, whereas aldo-keto
reductase family 1 member B10 (AKR1B10), IFN-α-inducible
protein 6 (IFI6), and matrix metallopeptidase 1 (MMP1) are
the most decreased genes in our analysis of SARS-CoV–infected
lung epithelial cells compared to mock controls. When these
DEGs from both MERS-CoV and SARS-CoV were subjected to
the analysis of overrepresented biological pathways and enriched
terms, several pathways related to inflammation and apoptosis
were commonly enriched (Supplementary Tables 4, 5).
Muted Expression of Acute Inflammatory
Genes Was Observed in the SARS-CoV-2
When Compared to MERS-CoV-2 and
SARS-CoV
Previous studies revealed that lung epithelial cells, dendritic
cells, and macrophages all express cytokines to some extent
during major viral infection causing cytokine storm. However,
little is known about the situation in COVID-19. Earlier
studies showed IFN-γ-related cytokine storm in SARS-CoV
infection, whereas MERS-CoV infection had delayed induction
of proinflammatory cytokines and suppression of innate antiviral
response. It is crucial to identify the primary source of
the cytokine storm in response to SARS-CoV-2 infection
and the underlying virological mechanisms. Our analysis of
shared DEGs between three coronaviruses resulted in 17
shared DEGs (Figure 2A), among which most genes are
related to acute inflammation. Figure 2B indicates that the
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TABLE 1 | Top 20 DEGs identified in the SARS-CoV-2 analysis.





194.45 9.90E-13 2.60E-10 1.0377
CXCL14 9547 C-X-C motif chemokine
ligand 14
100.64 4.25E-08 6.47E-06 0.8338
MYLK 4638 Myosin light chain
kinase
90.676 4.45E-08 6.71E-06 0.83025
OLFML2A 169611 Olfactomedin like 2A 413.24 4.58E-12 1.16E-09 0.79462
THBD 7056 Thrombomodulin 404.62 8.33E-11 1.96E-08 0.79168
VTCN1 79679 V-set domain
containing T cell
activation inhibitor 1
182.21 4.56E-08 6.79E-06 0.76269
MXRA5 25878 Matrix remodeling
associated 5
721.64 1.21E-11 2.96E-09 0.76162
METTL7A 25840 Methyltransferase like
7A
149.49 9.17E-08 1.34E-05 0.74126
MAP7D2 256714 MAP7 domain
containing 2
54.277 5.84E-06 0.000547 0.69934
GPNMB 10457 Glycoprotein nmb 2057.8 8.18E-11 1.96E-08 0.68713
Decreased DEGs
SPRR2D 6703 Small proline rich
protein 2D
365.31 1.79E-53 8.02E-50 −2.1217
IL36G 56300 Interleukin 36 gamma 271.41 6.98E-57 4.68E-53 −2.0691
SAA2 6289 Serum amyloid A2 575.93 3.57E-81 4.79E-77 −2.0679
CXCL5 6374 C-X-C motif chemokine
ligand 5
104.68 2.18E-35 2.44E-32 −1.8864
MX1 4599 MX dynamin like
GTPase 1
427.77 4.07E-37 4.96E-34 −1.7731
CSF3 1440 Colony-stimulating
factor 3
68.054 2.84E-28 1.81E-25 −1.6959
S100A8 6279 S100 calcium-binding
protein A8
1707.4 4.04E-52 1.35E-48 −1.6127
ICAM1 3383 Intercellular adhesion
molecule 1
1885 8.73E-45 1.95E-41 −1.5713
CFB 629 Complement factor B 789.4 2.86E-44 5.47E-41 −1.5634
MMP9 4318 Matrix
metallopeptidase 9
318.36 6.38E-26 3.42E-23 −1.5215
Genes were ranked based on the log fold change and adjusted p value (<0.05). The corresponding p values are adjusted, based on the false discovery rate using the
Benjamini–Hochberg procedure.
expression levels of these genes were lower in SARS-CoV-
2 when compared with the other two coronaviruses. Our
identification of a muted transcriptional response to SARS-
CoV-2 supports a model in which initial failure to rapidly
respond to infection results in prolonged viral replication
and subsequent recruitment of proinflammatory cells as the
infection progresses to induce alveolar damage in COVID-19.
Table 3 depicts the expression value of DEGs shared in all
three coronaviruses. It is evident that the expression of critical
acute inflammatory genes including TNF-α-induced protein 3
(TNFAIP3), C-X-C motif chemokine ligand 1 (CXCL1), and TNF
was lower in the SARS-CoV-2 dataset compared to two other
coronaviruses. These results may suggest that lung epithelial
cells do not directly contribute to the cytokine storm during
COVID-19 and that other immune cells appear to participate in
this process.
SARS-CoV-2 Elicits Suppressed Type I IFN
Response and Activation of Apoptotic
Gene Signature
Dissecting the DEGs involved in IFN response to coronavirus
infection in primary human lung epithelial cells revealed
that SARS-CoV-2 elicits a muted response that lacks robust
induction of a subset of cytokines including the type I IFN
compared to the response to MERS-CoV and SARS-CoV
(Figure 3A). Furthermore, our analysis revealed that in desperate
bid to control the viral propagation, SARS-CoV-2 infection
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TABLE 2 | Top enriched terms identified by functional analysis of the DEGs from SARS-CoV-2–infected human lung epithelial cells.
Enrichment terms Pathway/term ID Overlap GSEA library Adjusted p value
IL-17 signaling pathway hsa04657 21/93 KEGG 1.24E-15
TNF signaling pathway hsa04668 19/110 KEGG 4.76E-12
Signal transduction through IL1R h il1rPathway 06/36 Biocarta 0.006706
NF-κB activation by nontypeable Haemophilus influenzae h nthiPathway 05/29 Biocarta 0.013491
Plasminogen-activating cascade P00050 07/15 Panther 2.37E-07
Blood coagulation P00011 07/38 Panther 1.67E-04
Apoptosis signaling pathway P00006 07/102 Panther 0.038822
Hemostasis R-HSA-109582 27/552 Reactome 1.91E-04
Platelet degranulation R-HSA-114608 11/105 Reactome 2.81E-04
Lung fibrosis WP3624 11/63 Wikipathway 4.53E-07
Overlap: indicates the number of hits from the meta-analysis compared to each curated gene set library. Gene set functional analysis was performed using extended libraries of the
EnrichR tool. Enriched terms and pathways were ranked based on the p value. KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, Gene Ontology Biological Process; GSEA,
Gene Set Enrichment Analysis.
induced several apoptosis-related genes in human lung epithelial
cells compared to responses to MERS-CoV and SARS-CoV
(Figure 3B).
Downstream Analysis of DEGs Unique to
SARS-CoV-2 and Network-Based
Meta-Analysis Led to Pathways and Hub
Genes Related to Inflammation and
Vascular Dysfunction
A set of 221 DEGs unique to SARS-CoV-2 underwent
downstream analysis to understand the enriched pathways and
associated hub genes. Using BinGO enrichment clusters of
biological process (GO terms) associated with unique DEGs of
SARS-CoV-2 was generated, which revealed enriched pathway
clusters associated with immune responses/chemotaxis, blood
coagulation, apoptosis, vascular remodeling, and vascular cell
proliferation (Figure 4A). Supplementary Dataset 4 compiles
the complete list of GO: terms enriched in DEGs associated
with SARS-CoV-2 infection. We generated a PPI network by
integrating the InnateDB interactome with the original seed of
221 DEGs. An expanded PPI network was generated with 2,542
nodes representing the proteins and 4,457 edges representing
the interaction between these proteins. Network-based hub DEG
analysis (Figure 4B) identified ribosomal protein L9 (RPL9)
and SMAD family member 3 (SMAD3) to be the most highly
ranked hub genes that increased and decreased among the DEGs,
respectively, based on betweenness centrality and degree score.
The list of top 15 hub genes based on network topology scores is
shown in Table 4.
Identification of the Transcription Factors
and Regulatory Kinases Network
Upstream to the Unique DEGs Obtained
From SARS-CoV-2
To understand what lies to the upstream of the unique
DEGs identified from the SARS-CoV-2 infection, we used
X2K bioinformatics tool. The regulatory gene network analysis
resulted in identification of transcription factors and kinases
related to the DEGs. Network in Figure 4C shows the top kinases
and transcription factors related to our DEGs. The list of top
10 ranked transcription factors and protein kinases is shown
in Supplementary Table 4. This analysis revealed the most
important regulatory gene candidates that may be involved in the
formation of regulatory complexes. Mitogen-activated protein
kinase 1 (MAPK1) and MAPK3 are among the top kinases,
whereas SMAD3 and SMAD2 are among the top transcription
factors associated with the unique DEGs from lung epithelial cells
infected with SARS-CoV-2.
Distinct Pathways and Gene Signatures
Associated With SARS-CoV-2
After we removed the DEGs shared by three coronaviruses
(17 DEGs) and those shared between SARS-CoV-2 and MERS-
CoV (91 DEGs); and SARS-CoV-2 and SARS-CoV (9 DEGs),
a total of 221 DEGs remained that was specific to SARS-CoV-
2 (Figure 2A and Supplementary Dataset 1). Our interest was
to identify the distinct pathways that may participate in the
pathogenesis of COVID-19. Using the list of SARS-CoV-2–
specific DEGs, we conducted biological process (GO) analysis on
the unique set of DEGs using a Cytoscape plugin, BinGO tool.
Table 5 depicts the most distinct pathways and their associated
representative genes with its known function and expression fold
change that may have implication on the disease pathogenesis.
In the analysis, the following pathways were enriched. In
the apoptosis-related pathway, the expression of neuropilin 1
(NRP1), forkhead box O1 (FOXO1), and tumor protein p53
inducible nuclear protein 1 (TP53INP1) is increased, whereas
that of colony-stimulating factor 2 (CSF2) and NLR family pyrin
domain containing 1 (NLRP1) is decreased. Acute inflammation–
related genes included IL-6 receptor (IL-6R) that increased and
serpin family Amember 3 (SERPINA3), complement component
1s (C1S), serum amyloid A2 (SAA2), and complement factor
B (CFB) that decreased. Among vascular dysfunction–related
genes, vav guanine nucleotide exchange factor 3 (VAV3) and
transcription factor 4 (TCF4) are increased, while thymidine
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TABLE 3 | Shared DEGs between coronaviruses.
COVID-19 MERS-CoV SARS-CoV
Symbols Name logFC adj.P.Val logFC adj.P.Val logFC adj.P.Val
TNFAIP3 TNF-α-induced protein
3
−1.4397 6.31E-48 1.3062 8.28E-07 1.0224 0.010541
CXCL1 C-X-C motif chemokine
ligand 1
−1.2721 1.39E-38 0.88054 5.05E-07 0.54891 0.005485
C15orf48 chromosome 15 open
reading frame 48
−1.1055 3.28E-28 0.62913 0.024618 0.27721 0.048513
IL32 Interleukin 32 −1.0607 1.44E-21 0.55427 6.13E-06 0.4451 0.021275
CXCL2 C-X-C motif chemokine
ligand 2
−1.1072 1.87E-16 1.9732 6.51E-13 0.31032 0.025261
CXCL3 C-X-C motif chemokine
ligand 3
−1.2936 4.47E-15 1.5534 1.66E-07 0.49265 0.006207
IL1A Interleukin 1 alpha −0.90381 3.18E-13 0.79049 3.99E-05 −0.63885 0.029208
SERPINB1 Serpin family B
member 1
−0.65532 1.12E-09 0.2583 0.001145 −0.16797 0.034799
DUSP10 Dual specificity
phosphatase 10
0.49169 0.000102 0.43159 0.017097 0.24686 0.014842
TNF Tumor necrosis factor −0.72256 0.000217 0.32484 0.003589 0.19034 0.039241
BCL3 BCL3 transcription
coactivator
−0.57674 0.0004 0.45737 0.001256 0.53122 0.007329
IFI6 Interferon α-inducible
protein 6
−0.49295 0.009535 0.4471 0.02091 −0.63885 0.029208
RAB30 “RAB30, member RAS
oncogene family”
0.4949 0.023868 0.38751 0.000627 0.1745 0.048354
IRAK3 Interleukin 1 receptor
associated kinase 3
−0.50297 0.024857 0.27287 0.034926 −0.14418 0.034042
SLAMF7 SLAM family member 7 0.44487 0.02517 0.72071 1.59E-07 −0.23004 0.028654
DUSP1 Dual specificity
phosphatase 1
−0.34689 0.025301 2.1214 1.58E-20 0.24686 0.014842
Expression values of the shared genes from each analysis. The corresponding p values are adjusted, based on the false discovery rate using the Benjamini–Hochberg procedure.
phosphorylase (TYMP) and nuclear receptor subfamily 2 group
F member 2 (NR2F2) are decreased. Genes related to blood
coagulation included coagulation factor III/tissue factor (F3)
and protein S (PROS1) are increased, whereas IFN-γ receptor
1 (IFNGR1), integrin subunit β3 (ITGB3), and tissue factor
pathway inhibitor 2 (TFPI2) are decreased. Several pathways
associated with cardiovascular dysfunction were enriched by the
unique set of DEGs specific to SARS-CoV-2 infection. Table 6
summarizes the pathways and their associated genes that might
play a role in cardiovascular complications.
DISCUSSION
In the present study, we focus on defining transcriptional
responses to SARS-CoV-2 relative to MERS-CoV and SARS-
CoV. A major goal was to discover unique cellular responses to
SARS-CoV-2 among these three coronaviruses. We specifically
selected datasets generated in cultured human lung epithelial
cells infected with each of these three coronaviruses as this
cell type is the major interface between the environment and
the host and defends the lung against foreign substances and
pathogens. In general, our data show that overall transcriptional
footprints to SARS-CoV-2 infection were distinct from those to
the other two coronaviruses. Despite the decreased expression
of acute inflammatory and type I IFN genes in response to
SARS-CoV-2, we observed increased expression of several genes
associated with interleukin signaling, complement pathways, and
chemokines. This finding echoes with the previously published
study, which conducted RNAseq analysis to understand host
transcriptional response to influenza A virus and SARS-CoV-2 in
primary human bronchial epithelial cells (11). We used a publicly
available subset of RNAseq data (GSE147507) from this study to
compare it with independent datasets for SARS-CoV andMERS-
CoV. It is worth mentioning that the list of DEGs unique to
SARS-CoV-2 infection generated in our analysis was associated
with coagulation and vascular function, which may explain why
COVID-19 causes more systemic cardiovascular complications
than do MERS and SARS (4, 8).
By analyzing RNAseq dataset of lung epithelial cells infected
with SARS-CoV-2, we defined transcriptional signatures of 338
DEGs, including 92 increased and 246 decreased genes across the
datasets. Among the top 10 increased DEGs, IFITM10, CXCL14,
and MYLK are the most significantly increased genes. CXCL14
is a cytokine involved in immunoregulatory and inflammatory
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FIGURE 3 | Type 1 IFN response and apoptotic genes signature in three coronaviruses. (A) Heatmap representation of expression profiles for the type 1 IFN response
genes (GO:0060337) between coronaviruses. (B) Heatmap representation of expression profiles for the apoptotic gene signatures (GO:0042981) between
coronaviruses. Clustering of selected genes on the heatmap was performed by hierarchical clustering algorithm using Euclidean distance measure. Expression scale:
blue (low expression) to yellow (high expression).
TABLE 4 | Network-based hub genes of SARS-CoV-2 specific DEGs.
Label Degree Betweenness Expression
SMAD3 330 705,502.9 −0.32876
STAT1 223 437,249.9 −0.4737
SH3KBP1 178 358,520.9 −0.32778
HDGF 177 330,006.3 −0.38192
TUBB 173 263,526.3 −0.34572
NFKB2 138 213,825.4 −0.86093
ETS1 133 255,847.5 −0.43368
TUFM 116 174,412.6 −0.27641
UBC 106 115,3510 0
TRAF3 104 1,793,40.7 −0.43528
CCT5 99 147,216.3 −0.31476
RPL9 98 114,815.3 0.38872
TUBB4B 86 79,259.32 −0.38926
CSNK1E 84 158,782.5 −0.3193
S100A9 83 123,102.9 −1.0222
Top 15 genes prioritized based on topological parameters are shown. Expression levels are incorporated in the table from the transcriptome analysis result.
processes by mediating the chemotactic activity for monocytes
and therefore can be implicated in the immune cell infiltration
in the lung during SARS-CoV-2 infection (24). IFITM proteins
family inhibit the entry of a large number of viruses; however,
the exact role of IFITM10 as an antiviral agent remains unknown
(25). SAA2 is the most significantly decreased gene in our
analysis. SAA2 is a useful inflammatory marker in acute viral
infections such as influenza, but its decreased expression in our
analysis is consistent with the aberrant inflammatory response
of SARS-CoV-2 infection (26). Viral infection is marked by
the activation of immune system, which is evident from the
enrichment of several pathways, including IL-17, TNF, and
apoptosis signaling pathways among others (27). Patients who are
infected with COVID-19 may develop pneumonia and progress
to severe respiratory failure termed acute respiratory distress
syndrome, which may result in the development of lung fibrosis
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FIGURE 4 | Downstream analysis of SARS-CoV-2–specific DEGs. (A) Overrepresentation of pathways and Gene Ontology categories in biological networks identified
from DEGs unique to SARS-CoV-2. Significantly overrepresented biological processes based on GO terms were visualized in Cytoscape. The size of a node is
proportional to the number of targets in the GO category. The color represents enrichment significance—the deeper the color on a color scale, the higher the
enrichment significance. p values were adjusted using a Benjamini and Hochberg FDR correction. Analysis revealed the enriched pathways associated with immune
responses and chemotaxis, blood coagulation, apoptosis signaling pathway, vasculature remodeling, and vascular cell proliferation. (B) Network-based analysis of
hub DEGs. Interaction network of SARS-CoV-2 unique genes; red nodes represent increased and green nodes represent decreased DEGs. (C) Regulatory gene
network analysis of the top 10 enriched kinases (green) and transcription factors (red) using SARS-CoV-2 specific DEGs. Yellow nodes represent the intermediate
proteins in the regulatory network. Node size represents the significance of protein based on p value; the bigger the node size, the higher the significance value.
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TABLE 5 | Distinct pathways and related genes associated with SARS-CoV-2.
Gene Gene name Role logFold change Adj p-val
Apoptosis-related genes in COVID-19–infected lung epithelial cells
NRP1 Neuropilin 1 Regulation of apoptotic pathways 0.332 0.023326
FOXO1 Forkhead box O1 Important regulator of cell death acting downstream of
several signaling pathways including CDK1, PKB/AKT1 and
STK4/MST1
0.432 0.014544
TP53INP1 Tumor Protein P53
inducible nuclear
protein 1





Inhibits induction of apoptosis in several cell types −1.136 2.92E-11
NLRP1 NLR family pyrin
domain containing
1
Can induce pyroptosis, an inflammatory form of programmed
cell death
−0.302 0.032517
Acute inflammation–related genes in COVID-19–infected lung epithelial cells
SERPINA3 Serpin family A
member 3
Is a typical acute-phase protein secreted into the circulation
during acute and chronic inflammation
−1.194 1.26E-20
C1S Complement C1s Subunit of first component of the classical pathway of the
complement system, released in acute inflammatory response
−0.525 0.01783
SAA2 Serum amyloid A2 SAA2 encode acute phase proteins (ASAA) that are released









Important component of complement system and
inflammatory response
−1.563 5.47E-41




Vav3-induced cytoskeletal dynamics contribute to heterotypic














Suppression of COUP-TFII in venous ECs switched its
phenotype toward proatherogenic by up-regulating the
expression of inflammatory genes and down-regulating
antithrombotic genes
−0.370 0.007664
Blood coagulation–related genes in COVID-19–infected lung epithelial cells
F3 Coagulation factor
III, tissue factor
Enables cells to initiate the blood coagulation cascades, and
it functions as the high-affinity receptor for the coagulation
factor VII
0.384 0.0002
PROS1 Protein S Anticoagulant plasma protein, which helps to prevent




No known direct role −0.365 0.01711
ITGB3 Integrin subunit
beta 3





Protein can inhibit a variety of serine proteases including
factor VIIa/tissue factor, thus suppress coagulation
−0.316 0.022707
List of differentially expressed pathways and genes associated with them. Possible roles were extracted from STRING database, and the expression values were added from the
RNA-seq analysis results.
(28). Consistent with this report, several genes such as colony-
stimulating factor 3 (CSF3), endothelin 1 (EDN1), plasminogen
activator, urokinase (PLAU), and MMP9 were reported to be
differentially expressed in SARS-CoV-2 infection.
Previous studies revealed that lung epithelial cells,
macrophages, and dendritic cells express cytokines to some
extent during major viral infection causing cytokine storm.
Evidence for molecular mechanisms of cytokine storm in
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GO-ID p value Adjusted p value Overlap Associated genes
Vasculature
development
1944 4.77E-05 3.35E-03 13/273 VAV3, NRP1, ITGB3, NR2F2,
FOXO1, TYMP, ZC3H12A,




48514 1.20E-04 6.14E-03 11/220 VAV3, NRP1, ITGB3, ZC3H12A,
COL8A1, NR2F2, ITGA5,
EPHA2, TYMP, TGM2, S100A7
Leukocyte chemotaxis 30595 1.84E-04 7.54E-03 5/41 PDGFB, SAA2, IL6R, S100A9,
CXCL16
Cell adhesion 7155 2.79E-04 9.71E-03 21/710 NRP1, DST, ITGB3, PCDH7,
COL12A1,TNC, NPNT, NID1, F3,
MTSS1, FLRT3, FEZ1, CDH10,
LY6D, CLCA2, COL8A1, FAT2,




















1938 6.92E-04 1.80E-02 4/32 BMP2, ITGB3, PDGFB, F3
Angiogenesis 1525 7.31E-04 1.85E-02 8/152 VAV3, NRP1, ITGB3, ZC3H12A,
COL8A1, ITGA5, TYMP, S100A7




14910 1.97E-03 3.86E-02 3/20 IGFBP3, PDGFB, F3
Lymphocyte
chemotaxis




43535 2.62E-03 4.50E-02 3/22 EFNA1, PDGFB, EPHA2
The corresponding p values are adjusted, based on the false discovery rate using the Benjamini–Hochberg procedure.
COVID-19 remains limited. Earlier studies have shown IFN-
γ-related cytokine storm in SARS patients (29), while delayed
induction of proinflammatory cytokines and suppression of
innate antiviral response by the MERS-CoV (30). It is crucial to
identify the primary source of the cytokine storm in response to
SARS-CoV-2 infection and the virological mechanisms behind
the cytokine storm. Consistent to this model, our analysis of
shared DEGs between three coronaviruses resulted in 17 DEGs,
among which most molecules are related to acute inflammation.
It is evident that important acute inflammatory genes (e.g.,
TNFAIP3, CXCL1, and TNF) are decreased in SARS-CoV-2–
infected cells compared to other coronaviruses. These results
may suggest that the major source of cytokine storm in COVID-
19 is not lung epithelial cells, but possibly immune cell types.
These aberrant transcriptional responses to SARS-CoV-2 may
indicate low responses to infection, resulting in prolonged viral
replication and serious lung damage in COVID-19 (31).
Our study linked DEGs unique to SARS-CoV-2 infection
with pathway clusters related to immune responses, blood
coagulation, apoptosis, and vascular remodeling. Apoptosis,
which is a defense mechanism of hosts against the viral
infection, depends on the rapid programmed cell death to
curtail viral spread. Previous studies reported that SARS-CoV
has evolved sophisticated molecular strategies to trigger host
cell apoptotic defenses (32, 33). In our data, SARS-CoV-2
infection increased the expression of NRP1 and FOXO1. NRP1
has a regulatory role of apoptotic pathways, whereas FOXO1
is an important regulator of cell death acting downstream of
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several signaling pathways, including CDK1, PKB/AKT1, and
STK4/MST1 (34).
Evidence suggests elevation of D-dimer and fibrin/fibrinogen
degradation products in patients with COVID-19, highlighting
aggravated blood coagulation (8). A recent clinical study
examined seven lungs obtained during autopsy from patients
with COVID-19 (35). The study observed vascular endothelial
injury and widespread thrombus formation in pulmonary
vessels. Immunohistochemical staining of pulmonary vasculature
of COVID-19 showed alveolar capillary microthrombi were
nine times as prevalent in patients with COVID-19 compared
with influenza patients. In consistent with these reports, we
identified coagulation-related genes in SARS-CoV-2 infection,
including tissue factor that initiates the external coagulation
cascades. In contrast, SARS-CoV-2 suppressed the expression of
antithrombotic gene TFPI2, which inhibits a variety of serine
proteases including factor VIIa/tissue factor complex.
Despite the clinical impact, the information on the
mechanisms of COVID-19 and its cardiovascular complications
remains limited. A systems approach, involving unbiased
bioinformatics and network analysis, may help to identify
causative genes and integrated pathways as drug targets for
the improvement in disease management (36). Network-based
analysis of hub genes in the DEGs dataset unique to SARS-
CoV-2 infection resulted in prioritization of RPL9 as the
most highly ranked DEG that had increased expression, based
on betweenness centrality and degree score. The increased
expression of RPL9, a ribosomal protein, can be attributed to the
fact that virus hijacks the translational machinery of the host for
its survival by the mechanisms such as ribosome shunting and
phosphorylation of ribosomal proteins (37, 38).
Regulatory gene network analysis helps to understand what
lies upstream of the DEGs in cells infected with SARS-CoV-2. It
is important to find out the regulatory kinases and transcription
factors as they participate in the pathogenesis and the progression
of the virus infection (39). Among several kinases regulating the
expression of DEGs expression in our analysis, genes involved
in MAPK cascades (MAPK1, MAPK2, MAPK8, and MAP3K7)
have roles in host response to viral infection (40). SMAD3, an
effector molecule in the transforming growth factor-β signaling
pathway, is also an interesting candidate in our analysis as it
was the top hub gene in our network analysis and also the most
significant transcription factor in our regulatory gene analysis.
In the present study, SARS-CoV-2 reduced SMAD3 expression,
which is consistent with previous findings on the decreased
expression of SMAD3 during viral infection to overtake the host
innate antiviral mechanism (41, 42).
In conclusion, our study provides the snapshot of
transcriptional host responses to SARS-CoV-2 infection, in
which expression of various inflammatory genes is decreased.
These results may explain why many infected individuals
show no symptoms. Furthermore, our study revealed that
SARS-CoV-2 elicits muted antiviral type I IFN response,
which may result in prolonged viral replication. These findings
may also explain why SARS-CoV-2 infection has a longer
incubation period than other coronavirus infections. Our
analysis revealed expression of several genes related to apoptosis,
coagulation, and vascular function, which may contribute to
cardiovascular complications. Furthermore, our study has
identified a novel set of candidate transcriptomic signatures
unique to SARS-CoV-2 infection, which may guide the initial
efforts in the development of diagnostic or therapeutic tools
for COVID-19.
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